Tudor Investment Corporation »

Vaxcyte shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 84k 36.02
2025-06-30 $2.1M 64k 32.51
2023-06-30 $1.6M 31k 49.94
2023-03-31 $1.4M 38k 37.48

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Spdr S&P 500 Etf Trust - US ETP ETF Option Call Option (SPY)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Nvidia Corp - US Equity (NVDA)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Unitedhealth Group Inc - US Equity (UNH)
Utilities Select Sector Spdr Fund - US ETP ETF Option Call Option (XLU)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Palantir Technologies Inc - US Equity (PLTR)
Oracle Corp - US Equity Option Call Option (ORCL)
Micron Technology Inc - US Equity (MU)
Goldman Sachs Group Inc/The - US Equity Option Call Option (GS)
Apple Inc - US Equity (AAPL)

View all positions for Tudor Investment Corporation

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
BlackRock
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
D. E. Shaw & Co
Paradigm Biocapital Advisors
Westfield Capital Management Company
Kynam Capital Management
Deep Track Capital
Geode Capital Management
Jpmorgan Chase & Co

View all funds holding Vaxcyte